Small-Cap Biotechs: How to Separate The Contenders From The Pretenders
May 7th, 2009 | By Marc Lichtenfeld | Category: FeaturedI’m used to explosive gains in the biotech world, but I’ve never seen a moonshot quite like this… As I write (TIME), shares of Vanda Pharmaceuticals (Nasdaq: VNDA) are up 712% today.